(Q40649145)

22 September 2017

1 reference

title

Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection (English)

1 reference

22 September 2017

0 references

1 reference

Gonzalez-Peralta RP

1

1 reference

22 September 2017

Davis GL

series ordinal

2

1 reference

22 September 2017

Lau JY

series ordinal

3

1 reference

22 September 2017

publication date

1 August 1994

1 reference

22 September 2017

published in

Journal of Hepatology

1 reference

22 September 2017

volume

21

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

255-259

1 reference

Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Non-A, non-B post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Structure and organization of the hepatitis C virus genome isolated from human carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Clinico-pathological study of acute non-A, non-B post-transfusion hepatitis: histological features of liver biopsies in acute phase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

HCV RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Hepatitis C virus RNA in symptomless donors implicated in post-transfusion non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Antibody to hepatitis C virus and liver disease in volunteer blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

1 reference

7 January 2021

Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Cellular cytotoxicity against autologous hepatocytes in acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Autoimmune chronic active hepatitis: changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Autoimmune hepatitis in children and hepatitis C virus testing

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Hepatitis C viraemia in adults with type 2 autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Anti-GOR and hepatitis C virus in autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Immune response to GOR, a marker for non-A, non-B hepatitis and its correlation with hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

Detection of a Liver-Membrane Autoantibody in HBsAg-negative Chronic Active Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980405-2

7 January 2021

10.1016/S0168-8278(05)80405-2

Identifiers

DOI

1 reference

22 September 2017

1 reference